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Objective. To evaluate clinical trial evidence of the effectiveness of qigong exercise on depressive and anxiety symptoms.Methods.
Thirteen databases were searched from their respective inception through December 2012. Relevant randomized controlled trials
(RCTs) were included. Effects of qigong across trials were pooled. Standardized mean differences (SMDs) were calculated for
the pooled effects. Heterogeneity was assessed using the I2 test. Study quality was evaluated using the Wayne Checklist. Results.
Twelve RCTs met the inclusion criteria. The results of meta-analyses suggested a beneficial effect of qigong exercise on depressive
symptoms when compared to waiting-list controls or usual care only (SMD=−0.75; 95% CI, −1.44 to −0.06), group newspaper
reading (SMD=−1.24; 95%CI, −1.64 to −0.84), and walking or conventional exercise (SMD=−0.52; 95%CI, −0.85 to −0.19), which
might be comparable to that of cognitive-behavioral therapy (𝑃 = 0.54). Available evidence did not suggest a beneficial effect of
qigong exercise on anxiety symptoms. Conclusion. Qigong may be potentially beneficial for management of depressive symptoms,
but the results should be interpreted with caution due to the limited number of RCTs and associated methodological weaknesses.
Further rigorously designed RCTs are warranted.
1. Introduction
Mental disorders are prevalent among the general population.
It is estimated that 26.2% of Americans aged 18 and older
suffer from a diagnosable mental disorder in a given year [1],
and that about one in five adults inChina has a currentmental
disorder (1-month prevalence 17.5%) [2].Mental disorders are
reported to be more debilitating than most chronic physical
conditions [3].
Depression and anxiety disorders are common men-
tal disorders worldwide, which are significantly associated
with morbidity, disability, comorbidities, and mortality [4].
According toWorldHealthOrganization (WHO), depression
is ranked as the 4th global burden of disease; it is projected
that it will be the 2ndmost important cause of disability (after
heart disease) and the second-leading cause of disease burden
worldwide by the year 2020 [5]. Because of traditional beliefs
and attitudes to mental problems among general population
in many societies, patients with depression and anxiety
disorders may confront dilemmas and experience stigma,
which discourage them from seeking medical treatment and
psychological therapy. A recent survey in England suggested
that only a quarter of all those with mental problems were
in treatment [3]. Moreover, existing evidence suggests that
the efficacy and effectiveness of currently available antide-
pressants and psychotherapy seem unacceptably low [6]. Fur-
thermore, antidepressants may cause side effects in various
organic systems, making them unacceptable by some patients
[7]. Thus, seeking alternative and complementary therapies
for management of their symptoms is preferred by many
patients with depressive and anxiety disorders or symptoms.
2 Evidence-Based Complementary and Alternative Medicine
Qigong, a modality of traditional Chinese medicine
(TCM), is originally a form of ancient martial arts that has
been developed and used to improve physical fitness and
strength in China for thousands of years [8]. The basic com-
ponents of qigong include concentration, relaxation, med-
itation, breathing regulation, body posture, and movement
[8]. According to TCM philosophy, qigong aims to achieve
a harmonious flow of vital energy (qi) in the body and reg-
ulate the functional activities of the body through regulated
breathing, mindful meditation, and gentle movements. With
regular practice and rehearsal of the structured movements
as well as the atonement of mind and breath, practitioners
may experience greater improvement in strength and fitness.
Long-term practice of qigong may help to prevent illness,
maintain good health, and heal the body from diseases.
Basically, there are two types of qigong: internal qigong and
external qigong. Internal qigong or qigong exercise is self-
directed and involves the use of movements, meditation,
and controlled breathing pattern, whereas external qigong
is usually performed by experienced masters using their
hands to direct qi energy (emitted qi) onto the patient for
healing or treatment [9–11]. Although there is little scientific
evidence to support the emitted “qi” and its therapeutic
effects [12], qigong exercise is popularly practiced by a large
number of people in Chinese communities to improve their
health. Many styles of qigong, such as “The Five-Animal Play
(Wuqinxi),” “The Eight-Section Brocades (Baduanjin),” and
“Guolin Qigong,” have been developed. Generally, qigong
can be classified into two categories: dynamic qigong (dong
gong) and static qigong (jing gong). The former involves the
coordination ofmovements andmeditation, whereas the later
focuses on mind concentration and body relaxation without
physical movement [8]. Qigong is an easily adaptable form
of mind-body integrative exercise that can be practiced in
anyplace, and anytime, without any special equipment. It
is widely practiced by Chinese not only to improve their
physical health [9–11, 13–15], but also to control their emo-
tions, manage their stress or depressive/anxiety symptoms,
and enhance overall well-being.
In recent years, an increased number of studies have
documented the effect of qigong on depressive and anxiety
symptoms. The mechanisms underlying the possible antide-
pressive effect of qigong have also been speculated upon
[16–18]. However, clinical trial evidence on health benefits of
qigong for patients with depressive and anxiety disorders or
symptoms has not been critically examined yet. Although two
relevant systematic reviews [19, 20] have been publishedmost
recently, their conclusions are inconsistent and subject to bias
because of methodological flaws. In one review [19], the great
heterogeneity of participants (including healthy subjects,
subjects with chronic illnesses, and subjects with depression)
and a wide spectrum of outcomes (including mood, anxiety,
psychological well-being, self-efficacy, and quality of life)
included in that review, coupled with selective meta-analysis
of only three of the fifteen included studies, undermined the
reliability of its conclusive statements. In another review [20],
the conclusive statements were rather evasive due to a great
diversity of study populations (including college students and
patients with cancer, severe chronic pain, Parkinson’s disease,
or other chronic illnesses) examined in the review and failure
to perform meta-analysis of the results of the included trials.
In light of the limitations of the previous reviews, the purpose
of the present systematic review was to critically evaluate the
overall effectiveness of qigong as a form of mind-body inte-
grative exercise on depressive and anxiety symptoms using
standardized inclusion criteria for each of the PICO (par-
ticipants, interventions, comparisons, and outcomes) ele-
ments as detailed in the Cochrane Handbook [21].
2. Methods
2.1. The Literature Search. The following electronic data-
bases were searched from their respective inception
through December 2012: PubMed/MEDLINE, CENTRAL,
CINAHL, EMBASE, AMED, Qigong and Energy Medicine
Database, China Academic Journals Full-Text Database,
Medicine/Hygiene Series, China Proceedings of Conference
Full-Text Database, China Master’s Theses Full-Text Data-
base, China Doctoral Dissertations Full-Text Database,
Taiwan Electronic Theses and Dissertation System, Taiwan
Electronic Periodical Services, and Index to Taiwan Peri-
odical Literature System. The search terms used for this
systemic review include qigong, qi-gong, qi gong, chi chung, chi
gong, qi chung, qi-training, depression, depressive, depressed,
dysthymia, dysthymic, anxiety, burnout, mental, and psychia-
tric. Both traditional and simplified Chinese translations of
these terms were used in Chinese databases. Reference lists
of all included studies, relevant reviews, and other archives
of the located publications were hand-searched for further
relevant articles.
2.2. Study Selection. The following criteria were applied for
study selection.
(1) Types of Studies. All RCTs aiming to examine the
effects of qigong on depressive and anxiety symptoms were
included. Nonrandomized controlled clinical trials (CCTs)
were excluded due to their susceptibility to bias. Noncon-
trolled observational studies and case reports were excluded
due to lack of significant evidence.
(2) Types of Participants. Adult men and women aged 18 and
over (with no upper age limit), who were defined by the
authors of the trial as having depression and anxiety disorders
or elevated depressive symptoms. Given the limited number
of studies conducted amongpatientswith primary depression
or anxiety disorders, studies of qigong among patients with
depressive/anxiety symptoms secondary to chronic illnesses
were included, but the studies among patients with severe
or specific conditions (e.g., cancer, asthma, congestive heart
failure, Parkinson’s disease, fibromyalgia, and severe chronic
pain) were excluded. Studies among individuals with burnout
syndrome or insomnia were also included if depressive
symptoms were measured in the trial. Studies among healthy
subjects, children, and pregnant women were excluded.
(3) Types of Intervention. Studies comparing any style of
qigong with waitlist/other forms of exercise/other types
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of intervention (e.g., psychotherapy) or studies comparing
qigong plus another intervention versus the other interven-
tion alone were included. Studies comparing qigong plus
another intervention versus qigong alone were excluded.
Studies thatmeasured outcomes immediately before and after
a single qigong session (immediate effects of qigong) were not
included due to high risk for biases.
(4) Types of Outcome Measures. The focuses of this review
were on depressive and anxiety symptoms. Studies including
outcome measures of depressive and/or anxiety symptoms
either as continuous measures or as dichotomous outcomes
were included. Studies focusingmood status, perceived stress,
or other normal psychological reactions were excluded. Stud-
ies in which depressive and anxiety symptomsweremeasured
with validated instruments that were designed to assess the
severity of depressive and anxiety symptoms or to screen
depressive and anxiety disorders were included. Studies in
which depressive and anxiety symptoms were measured
merely with nonspecific instruments that were not designed
to screen depressive and anxiety disorders or to assess the
severity of depressive and anxiety symptoms specifically were
excluded. Studies focusing on other self-report outcomes
(such as sleep quality) or biomarkers (such as cortisol) were
not included if depressive and/or anxiety symptoms were not
measured in the trials.
2.3. Data Extraction and Quality Assessment. For each
included study, data were extracted from the original paper
independently by one main researcher and then verified by
another researcher. Data extracted included quality criteria,
participants, quality and dosage of intervention, outcome
measures, and results. Any discrepancies were discussed until
consensus was achieved. The methodological quality of each
trial was evaluated using the Wayne Checklist [22]. It was
commended that this checklist was comprehensive, adaptable
to clinical context, and compatible with recent developments
in statistics and experimental design [23].The checklist asses-
ses study quality with respect to reporting of the following
criteria: randomization, details of randomization methods,
clear inclusion and exclusion criteria, blinding of outcome
assessors, description of withdrawal and dropouts, sample
size estimates or justification, use of appropriate statistical
analyses, details of qigong intervention, and qualification of
the qigong instructors. Since blinding both investigators and
participants were generally impossible for studies of qigong,
the checklist only assessed if the outcome assessors were
blind to treatment allocation. A trail was considered to have
used intention-to-treat analysis if all the participants were
analyzed with no difference in number between pre- and
postintervention. The risk of bias in the included studies
was assessed using the framework for methodological quality
recommended by Ju¨ni and colleagues [24]. According to
this framework, biases fall into four categories: selection bias
(biased allocation to comparison groups), performance bias
(unequal provision of care apart from intervention under
evaluation), detection bias (biased assessment of outcomes),
and attrition bias (biased occurrence of loss to follow-
up).
2.4. Data Synthesis and Analysis. Meta-analyses of the
results reported in the included studies were performed
usingReviewManager 5.2 (http://ims.cochrane.org/revman).
Effect sizes were calculated for each trial using Hedge’s g
[25]. Standardized mean differences (SMDs) were calculated
for the pooled effects. We interpreted the SMDs using the
following “rule of thumb”: 0.2 represents a small effect, 0.5 a
moderate effect, and 0.8 a large effect [26]. A random-effects
modelwas used for data synthesiswhen an outcomewasmea-
sured by different measures, and a fixed-effects model was
used when the outcome was measured by the same instru-
ment. The 𝜒2 statistic, together with the 𝐼2 statistic, was used
to assess heterogeneity. Studies with an 𝐼2 statistic of >75%
were considered to have a high degree of heterogeneity, those
with an 𝐼2 statistic of 50%–75% were considered to have
a moderate degree of heterogeneity, and those with an 𝐼2
statistic of 25%–50% were considered to have a low degree
of heterogeneity [27]. Sensitivity analyses were conducted by
omitting one study in turn and evaluating the influence of
a single study on the overall pooled effect. Publication bias
was not examined due to the limited number of studies (<10)
included in each analysis. A value of 𝑃 < 0.05was considered
statistically significant.
Where an outcome was assessed by more than one tool
in a trial, we included the main outcome measure (identified
as the first outcome reported in the results section or the
outcome reported in the abstract) only in the meta-analysis.
For publications in which only 𝑃 values were reported but
the data on continuous outcomemeasures were not available,
we wrote to the corresponding authors for relevant data.
Trials using dichotomous data as primary outcomes were
not included in our meta-analyses. Trials presenting median
and interquartile range (indicators of skewed data) rather
than mean and standard deviation were also not included
in our meta-analyses due to impossibility of transformation
between them. Where trials had more than two arms (e.g.,
qigong, other exercises, or waiting-list), we used data from
the exercise arm for two separate comparisons: qigong versus
other exercises and qigong versus waiting-list control.
3. Results
3.1. Results of the Literature Search. Our database searches
identified 503 potentially relevant articles, of which 446
articles were excluded after screening of title or abstract.
Full reports of 57 studies were acquired and 45 were further
excluded due to that they were (1) not a clinical trial,
(2) uncontrolled observational studies, (3) nonrandomized,
controlled clinical trial, (4) studies comparing qigong plus
another intervention versus qigong alone, (5) studies focusing
on other outcomes, (6) studies on acute effects of qigong, (7)
studies conducted in healthy subjects, (8) publications focus-
ing on qigong-induced mental disorders, and (9) duplicate
publications (Figure 1).
3.2. Description of Included Studies. Twelve RCTs [28–39]
met our inclusion criteria. These studies were conducted
in Hong Kong [28–30, 35–37], Sweden [34], and Main-
land China [31–33, 38, 39], respectively. Ten of them were
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Publications identified (𝑛 = 503)
Full text for further evaluation (𝑛 = 57)
Publications excluded after screening of title and
abstract (𝑛 = 446)
RCTs included in this review (𝑛 = 12)
Excluded after obtaining the full text (𝑛 = 45)
∙ Not a clinical trial (𝑛 = 15)
∙ Studies focusing on other outcomes (𝑛 = 1)
∙ Studies with qigong provided to both groups (𝑛 = 2)
∙ Studies on immediate effects of qigong (𝑛 = 2)
∙ Studies conducted in healthy subjects (𝑛 = 4)
∙ Publications focusing on qigong-induced mental
disorders (𝑛 = 10)
∙ Duplicate publications (𝑛 = 2)
RCTs included in meta-analysis (𝑛 = 10)
Excluded from data synthesis (𝑛 = 2)
∙ Noncontrolled observational studies (𝑛 = 7)
∙ Nonrandomized, controlled clinical trials (𝑛 = 2)
Figure 1: Selection process for included studies.
published in peer-review journals with full texts and the
remaining twowere unpublishedmaster theses [33, 39]. Eight
RCTs were published in English and two [31, 32] were pub-
lished in Chinese. The characteristics of the included studies
are shown in Table 1.
Participants in the included studies includedpatientswith
clinical depression [28, 33], depressed elders with chronic
illnesses [35–37], patientswith burnout syndrome [34], adults
with depressive mood [29], women with perimenopausal
syndrome and depression [32], and patients with depressive
symptoms secondary to chronic conditions including hyper-
tension [30], diabetes mellitus [31, 39], and subhealth status
[38]. Sample sizes in the included studies ranged from 38 to
145 with a total of 936 participants including 428 subjects in
the qigong groups and 508 subjects in control groups.
Qigong exercise used in the included studies included
the Eight-Section Brocades (Baduanjin) [31, 32, 35–37, 39],
Wuqinxi [33, 38], GuolinQigong [30], andDejianmind-body
intervention based on traditional Shaolin qigong practice [28,
29].The style of qigong was not mentioned in one study [34].
Duration of qigong intervention ranged from 4 weeks [29] to
16 weeks [30, 36]. All included studies just only examined the
effect of qigong immediately following the qigong interven-
tion, and no study had examined the effect of qigong inter-
vention after a period of followup.
A two-armed, parallel group design was employed in
nine studies, in which qigong was compared with newspaper
reading and discussion [35, 36], cognitive-behavioral therapy
[29], walking [32, 33] or conventional exercise [30], usual care
or treatment [31, 34, 36], and waiting-list controls [28, 38,
39]. Three trials were conducted with a three-armed, parallel
group design. In one trial qigong was compared with cogni-
tive-behavioral therapy and waiting-list controls [28]. In
another trial qigong group was compared with a walking
group and a waiting-list control group [32]. In the last trial
qigong group was compared with a mindful relaxation group
and a waiting-list control group [39].
Regarding outcomemeasures, depressive symptoms were
assessed in all of the included studies, whereas anxiety symp-
toms were assessed only in four studies.The depression scales
applied in the examined studies included Geriatric Depres-
sion Scale [35–37], Beck Depression Inventory [28–30],
Hospital Anxiety andDepression Scale [34],HamiltonRating
Scale for Depression [28, 36], Hamilton Depression Rating
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Study or subgroup
Chan et al., 2012
Chan et al., 2011
Total (95% CI)
Mean
17.94
6.3
SD
2.7
6.67
Total
17
20
37
Mean
14.94
8.9
SD
0.6
7.91
Total
17
20
37
Weight
49.2%
50.8%
100%
IV, random, 95% CI
1.5 [0.73, 2.27]
Experimental Control
Std. mean difference Std. mean difference
IV, random, 95% CI
0 1 2
Favours qigong Favours control
Heterogeneity: 𝜏2 = 1.58; 𝜒2 = 13.28, df = 1 (𝑃 = 0.0003); 𝐼2 = 92%
−0.35 [−0.97, 0.28]
−2 −1
Test for overall effect: 𝑍 = 0.61 (𝑃 = 0.54)
0.56 [−1.25, 2.37]
Figure 2: A forest plot of the meta-analysis of two studies comparing qigong to cognitive-behavioral therapy for changes in depressive
symptoms.
Scale [33], Self-rated Depression Scale [31, 38, 39], and Cen-
ter for Epidemiologic Studies Depression Scale [32]. Anxiety
scales applied in these studies included Beck Anxiety Inven-
tory [30], Hospital Anxiety and Depression Scale [34], and
Self-rated Anxiety Scale [38, 39].
3.3. Effects of Qigong on Depression or Symptoms. Of the
included 12 studies, nine suggested a favorable effect of qigong
on depressive symptoms [28, 29, 31–33, 35, 36, 38, 39] and
three did not [30, 34, 37]. Because of heterogeneity of controls
across the included studies, it would be inappropriate to
synthesize the results of these studies directly, and so the
effects of qigong on depressive symptoms were pooled by
types of controls in this review. Ten trials were included in
our meta-analyses. Two trials could not be included. In one
trial, the values ofmedian and interquartile range, rather than
mean and standard deviation, were reported for outcome
measures [34]. In another trial, only mean differences were
presented [39].
Comparison 1: Qigong versus Cognitive-Behavioral Therapy
(CBT). Two trials [28, 29] compared the effect of qigong
on depressive symptoms with that of cognitive-behavioral
therapy. One trial [28] focused on outpatients with clinical
depression and another [29] focused on adults with depres-
sive mood. Both trials suggested no intergroup difference.
Their results were pooled and the pooled SMD was 0.56
[−1.25, 2.37], indicating an insignificant effect (𝑃 = 0.54; Fig-
ure 2). There was a high degree of heterogeneity (𝐼2 = 92%).
Comparison 2: Qigong versus Walking or Conventional Exer-
cise. Three trials compared the effect of qigong with that of
walking and conventional exercise [30, 32, 33]. Participants
in these studies included women with perimenopausal syn-
drome and depression [32], patients with hypertension and
depressive symptoms [30], and patients with mild or moder-
ate depression [33]. Two studies suggested a beneficial effect
of qigong [32, 33] and the remaining one did not [30]. Their
results were pooled and the pooled SMD was −0.52 [−0.85,
−0.19], indicating a moderate effect (𝑃 < 0.01; Figure 3). A
low degree of heterogeneity was indicated (𝐼2 = 35%). Exclu-
sion of the trial conducted by Cheung et al. [30] did not alter
the pooled effect but resolved heterogeneity (SMD = −0.67
[−0.99,−0.34];𝑃 < 0.001; 𝐼2 = 0%). Exclusion of the trial con-
ducted byQiu et al. [33]mildly altered the pooled effect (SMD
= −0.41 [−0.77, −0.04]; 𝑃 < 0.05; 𝐼2 = 30%). Exclusion of the
trial conducted by Ma et al. [32] altered the pooled effect sig-
nificantly (SMD = −0.49 [−1.09, −0.10]; 𝑃 > 0.05; 𝐼2 = 66%).
Comparison 3: Qigong versus Group News Reading. The effect
of group support on depressive symptomswas adjusted in two
trials [35, 36], in which group qigong training was compared
to group newspaper reading. Both studies suggested a sig-
nificant intergroup difference in favor of qigong. The pooled
SMD was −1.24 [−1.64, 0.84], indicating a large effect (𝑃 <
0.001; Figure 4).There was a high degree of heterogeneity (𝐼2
= 77%).
Comparison 4: Qigong or Qigong Plus Usual Care versus
Waiting-List Controls or Usual Care Only. Four trials [28, 32,
38, 39] compared qigong to waiting list controls and three
trials [31, 34, 37] compared qigong plus usual care to usual
care only. As mentioned before, two trials [34, 39] could
not be included for meta-analysis. One reported negative
results [34], whereas another suggested positive results [39].
Of the remaining five studies that could be included formeta-
analysis, four trails [28, 31, 32, 38] suggested a favorable effect
of qigong on depressive symptoms and only one trial [37] did
not.Their results were pooled and the pooled SMDwas −0.75
[−1.44, −0.06], indicating a moderate effect (𝑃 = 0.03, Figure
5). There was a high degree of heterogeneity (𝐼2 = 89%).
Exclusion of the trial conducted by Chan et al. (2012) [28]
significantly altered the pooled effect (SMD = −0.59 [−1.36,
0.18]; 𝑃 = 0.13; 𝐼2 = 90%). Exclusion of the trial conducted
by Liu et al. (2012) [31] mildly altered the effect (SMD= −0.82
[−1.72, 0.08]; 𝑃 = 0.07; 𝐼2 = 91%). Exclusion of the trial
conducted byMa et al. (2011) [32] also altered the effect (SMD
= −0.48 [−1.04, 0.08]; 𝑃 = 0.09; 𝐼2 = 76%). Exclusion of
the trial conducted by Tsang et al. (2003) [37] increased the
pooled effect (SMD = −0.99 [−1.68, −0.30], 𝑃 < 0.01; 𝐼2 =
86%). Exclusion of the trial conducted by Wang et al. (2010)
[38] altered the pooled effect mildly (SMD = −0.85 [−1.74,
−0.04], 𝑃 = 0.06; 𝐼2 = 91%).
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Study or subgroup
Cheung et al., 2005
Ma et al., 2011
Qiu et al., 2011
Total (95% CI)
Mean
5.62
18.22
18.46
SD
6.38
4.41
7.58
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37
49
31
117
Mean
7.32
20.89
24.89
SD
9.5
4.72
8.03
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38
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113
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100%
IV, random, 95% CI
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0 1 2
Favours qigong Favours control
−2 −1
−0.21 [−0.66, 0.25]
−0.58 [−0.99, −0.17]
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Heterogeneity: 𝜏2 = 0.03; 𝜒2 = 3.09, df = 2 (𝑃 = 0.21); 𝐼2 = 35%
Test for overall effect: 𝑍 = 3.07 (𝑃 = 0.002)
−0.52 [−0.85, −0.19]
Figure 3: A forest plot of the meta-analysis of three studies comparing qigong to walking or conventional exercise for changes in depressive
symptoms.
Study or subgroup
Tsang et al., 2006
Tsang et al., 2012
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3.19
7.52
SD
2.12
4.18
Total
48
21
69
Mean
6.15
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0 1 2
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−1.56 [−2.07,−1.06]
−0.69 [−1.35,−0.03]
−2 −1
−1.24 [−1.64, −0.84]
Figure 4: A forest plot of themeta-analysis of two studies comparing qigong to group newspaper reading for changes in depressive symptoms.
Study or subgroup
Chan et al., 2012
Liu et al., 2012
Ma et al., 2011
Tsang et al., 2003
Wang et al., 2010
Total (95% CI)
Mean
17.94
51.53
18.22
6.13
35.34
SD
2.7
8.61
4.41
4.14
8.46
Total
17
33
49
24
40
163
Mean
23.5
55.93
25.48
5.16
38.64
SD
4.45
9.02
4.14
4.14
8.61
Total
17
36
50
26
40
169
Weight
17.8%
20.6%
20.8%
19.9%
20.9%
100%
IV, random, 95% CI
Experimental Control
Std. mean difference Std. mean difference
IV, random, 95% CI
0 1 2
Favours qigong Favours control
−1.47 [−2.24, −0.71]
−0.49 [−0.97, −0.01]
0.23 [−0.33, 0.79]
−0.38 [−0.83, 0.06]
−1.68 [−2.15,−1.22]
Heterogeneity: 𝜏2 = 0.54; 𝜒2 = 34.81, df = 4 (𝑃 < 0.00001); 𝐼2 = 89%
Test for overall effect: 𝑍 = 2.13 (𝑃 = 0.03)
−2 −1
−0.75 [−1.44, −0.06]
Figure 5: A forest plot of the meta-analysis of five studies comparing qigong to waiting list controls or qigong plus usual care to usual care
only for changes in depressive symptoms.
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Table 2: Quality assessment of the included studies.
Studies Randomizationemployed
Randomization
methods
Inclusion
and
exclusion
criteria
Outcome
assessors
blinded
Withdrawal
and
dropouts
Sample size
estimation
Intention-
to-treat
analysis
Intervention
described
Qualification
of the trainer
Chan et al.,
2012 [28] Y N Y Y Y N Y Y Y
Chan et al.,
2011 [29] Y
Block
randomization Y Y N Inappropriate
∗ NA Y Y
Cheung
et al., 2005
[30]
Y
A randomization
list prepared by a
statistician
Y N Y Y Y Y Y
Liu et al.,
2012 [31] Y
Random digit
number table Y N Y N N Y Y
Ma et al.,
2011 [32] Y N Y N N N NA Y N
Qiu, 2011
[33] Y
Random digit
number table Y N N N NA Y Y
Tsang et al.,
2003 [37] Y Drawing of lots Y N Y Y Y Y Y
Stenlund
et al., 2009
[34]
Y
Computer-
generated
number
Y Y Y N Y Y Y
Tsang et al.,
2012 [35] Y N Y Y Y Y N Y Y
Tsang et al.,
2006 [36] Y N N N N N NA Y Y
Wang et al.,
2010 [38] Y N N N N N NA Y N
Wang, 2008
[39] Y
Computer-
generated
number
Y N Y N N Y Y
N: not reported; NA: not applicable; Y: yes. ∗Sample size was not calculated according to power and effect size.
3.4. Effects of Qigong on Anxiety Symptoms. The effect of
qigong on anxiety symptomswas examined in four studies, in
which participants included patients with burnout syndrome
[34], subjects with sub-health status [38], patients with
hypertension [30], and patients with diabetes mellitus [39].
Only one [38] of them suggested a significant difference
in the effects of qigong on anxiety symptoms between the
qigong intervention groups and the control groups, whereas
the other trials [30, 34, 39] suggested otherwise.
3.5. Study Quality Assessment. Quality assessment for each
trial was presented in Table 2. As shown in the table, inclusion
and exclusion criteria were clearly defined in ten trials [28–
36, 39]. Randomizationmethodwas reported in seven studies
[29–31, 33–35, 39]. Allocation concealment was adequate
only in five studies [28, 30, 35, 37, 39]. Blinding of outcome
assessors was applied only to four studies [28, 29, 35, 36].
The number of those who did not complete the intervention
program and thus did not provide data of postintervention
assessment was reported in seven studies [28, 30, 31, 34–36,
39], of which intention-to-treat analyses were performed only
in four trials [28, 30, 34, 35]. For remaining five studies [29,
32, 33, 37, 38] in which the rate of dropout was not reported
and intention-to-treat analysis was not specified, we assumed
that all participants in those studies have completed the
intervention program. Sample size estimation was calculated
or justified appropriately only in three studies [30, 34, 36].
4. Discussion
In this review, clinical trial evidence of the effectiveness
of qigong on depressive and anxiety symptoms was com-
prehensively and critically examined. The strengths of the
current review include the use of a systematic and transparent
literature search, standardized inclusion criteria based on
PICO, and careful meta-analyses of the results reported in
the included studies by types of controls. On the basis of
available evidence, our review demonstrated a beneficial
effect of qigong on depressive symptoms when compared to
waiting-list controls or usual care alone (SMD = −0.75; 95%
CI, −1.44 to −0.06), group newspaper reading (SMD = −1.24;
95% CI, −1.64 to −0.84), and walking (SMD = −0.52; 95%
CI, −0.85 to −0.19), which might be comparable to that of
cognitive-behavioral therapy (𝑃 = 0.54). These findings are
in alignment with a systematic review of physical exercise for
depression [40]. However, interpretation and generalization
of our results should be treatedwith caution due to the limited
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number of the included studies in each comparison and the
methodological problems inherent in these studies.
Clinically, there are a number of subtypes of depression.
Usually, depression can be classified into primary depression
and secondary depression [41]. Depression can also be classi-
fied into major depression, minor depression (sub-threshold
depression), and chronic depression including dysthymic
disorder [41–43]. In addition, a large number of individuals
may have elevated depressive symptoms that do not meet
the diagnosis criteria for clinical depression. Onset or devel-
opment of depression may be induced by a number of risk
factors. It is suggested that approximately one-third of the risk
is inherited or genetic-related and two-thirds is environmen-
tal [6]. Generally, primary depression or major depression
disorder may be induced by the interaction of genetic and
environmental factors, whereas secondary depression, minor
depression, and elevated depressive symptoms aremore likely
to be induced by environmental factors such as prolonged
stress, chronic illnesses, or adverse life events.
Currently, studies of qigong on primary depression and
anxiety disorders are still rare. Among the studies included in
this review, only two RCTs [28, 33] focused on patients with
clinical depression as a primary mental problem. Although
a desirable effect of qigong on depressive symptoms was
observed in the two RCTs, the finding may be biased since all
participants were prescribed with antidepressants. Thus, it
was difficult to segregate the effects of qigong from the effect
of medication [28]. Another RCT [37] focusing on patients
with diagnosed burnout syndrome suggested no significant
effect of qigong on depressive symptoms. Two additional
RCTs [35, 36] among older adults with clinical depression
also demonstrated a beneficial effect of qigong on depressive
symptoms, but the results could not be generalized to all
patients with depressive disorders for that all participants
in the two studies were older adults whose depressive
symptoms were secondary to chronic illnesses. While major
depression can develop at any age, the median age at onset
is 32 [44]. It has been reported that major depression is the
leading cause of disability in the US for ages 15–44 [5]. To
date, clinical trials of qigong particularly focusing on young
adults with major depression are still limited. In the absence
of RCTs in the field, nonrandomized CCTs may provide
alternative evidence. Two relevant, small-scale CCTs [45, 46]
could be identified and a mildly significant effect of qigong
on depressive and anxiety symptoms was demonstrated
in the two trials. Unfortunately, such data are highly
susceptible to bias and hence, provide, little scientific evi-
dence.
Conducting research of qigong among patients with
primary depression facesmany challenges. Amajor challenge
may be the difficulty in recruiting sufficient participants into
the trial, since many patients with depression are unwilling
to participate in such type of informed group training due
to perceived social stigma and concern for personal privacy.
Instead, many studies examined in this review were con-
ducted among patients with depressive symptoms secondary
to chronic illnesses.
Although a beneficial effect of qigong on depres-
sive symptoms among patients with chronic illnesses was
observed in most of the studies examined in this review,
the result may not be generalized to patients with severe
physical problems. For instance, one RCT [47] and two
CCTs [48, 49] suggested no significant effect of qigong on
depressive symptoms among cancer patients. Another RCT
[50] also suggested no beneficial effect of qigong on depres-
sive symptoms among patients with Parkinson’s disease.
However, a recent study [51] suggested a beneficial effect of
qigong on depressive symptoms in women with breast can-
cer. Thus, the efficacy and effectiveness of qigong on depres-
sive symptoms for patients with different physical problems
should be further tested in future studies.
It should also be noted that a high risk of bias might
have existed in the included studies due to some inherent
methodological weaknesses. In most of them, qigong was
preferentially provided to the intervention groups as a group
therapeutic modality, whereas the control groups did not
have a matched number of social contact hours with copar-
ticipants. Thus, performance bias might have existed in these
trials and a placebo effect might have occurred in patients
who benefited from participation in group activities and the
contact with other persons. Blinding outcome assessors for
group allocation was unclear in 8 RCTs [30–34, 37–39], and
selection bias might have been introduced in these trials.The
proportion of dropouts and withdrawals were recorded in 7
RCTs [28, 30, 31, 34–36, 39]. Attrition bias might have been
introduced in these trails. Of them, intention-to-treat analysis
was not applied to three RCTs [31, 36, 39]. The probability of
bias for the results might exist in these studies. In addition,
sample size was not appropriately justified in 9 RCTs [28,
29, 31–33, 35, 37–39]. It is unclear if the sample sizes in
some studies were large enough to avoid type II error. Lastly,
depressive and anxiety symptoms were only measured before
and immediately after the qigong intervention programs in
all of the included studies. None of them had followed the
participants up for a period of time after the intervention.
Thus, there was little evidence of the long-term effect of
qigong on depressive symptoms.
An examination of the included studies also reveals a
great disparity in the dosage and intensity of qigong exercise
across the studies examined, which may make it difficult to
compare the results of these studies. As shown in Table 1,
there were many forms of qigong applied in the included
studies, with different duration of group practice and recom-
mendations for individual home practice. The frequency of
qigong practice at home was reported in some studies but
not in others. Most importantly, the amount of home pra-
ctice of qigong was not measured nearly in all of those stud-
ies in which group practice of qigong was not applied
daily. Given that some studies have suggested a relationship
between amount of qigong practice and health outcomes [52],
a beneficial effect might have not been observed in those
participants with insufficient dosage and intensity of qigong
practice.Therefore, the dosage or intensity of qigong exercise,
including individual home practice, should be measured for
each participant and taken into account in data analysis in
future studies.
Although no adverse effects of qigong were reported in
the included studies, it should be noted that qigong-induced
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mental disorders were documented in some other publica-
tions [53, 54]. It was suggested that qigong-induced mental
disorders or “qigong-precipitated psychoses” were resulted
from “unrealistic expectation of acquiring supernormal pow-
ers” or “inappropriate practice of qigong” [54]. Thus, it is
not recommended to use qigong intervention for manage-
ment of depressive symptoms among patients with severe
mental disorders, especially younger patients for high risk of
unrealistic expectations. Indeed, we have tried to locate all
controlled trials of qigong on all types of mental disorders or
disturbances but found that studies of qigong on other types
of mental disorders or disturbances rather than depressive
and anxiety disorders were rare.
Our review has some limitations. The first one may be
the potential incompleteness of the evidence reviewed, a
common concern for any systematic reviews.The second one
may be that we have not contacted with relevant authors to
identify unpublished or ongoing studies. Thus, publication
bias might have existed in the included studies and the effect
sizes of qigong might have been overestimated since positive
trials are more likely to be published than negative trials.
In addition, we could not examine the effects of dosage and
intensity of qigong and also could not differentiate the effects
of dynamic and static qigong on depressive symptoms due
to the limited number of the included studies. Moreover, we
could not examine the effects of qigong on other outcomes
such as quality of life for patientswithmental health problems
due to that the focus of the current systematic review was
on depressive and anxiety symptoms. These issues should be
addressed in future studies.
5. Conclusion
To summarize, this review shows that there is only prelim-
inary evidence that qigong may be potentially beneficial for
management of depressive symptoms. However, the results
should be interpreted with caution due to limited number
of studies and associated methodological weaknesses. The
results of this review may not be applicable to patients with
primary depression since most of the included studies were
conducted among patients with secondary depression, minor
depression, or elevated depressive symptoms.The resultsmay
also not be applicable to patients with depression secondary
to adverse life events since most of the included studies were
conducted among patients with chronic illnesses. The results
may not be generalized to young adults with mental health
problems since few studies were conducted particularly
among this group of clients. Moreover, it seems that qigong
is ineffective in relieving depressive symptoms for patients
with severe physical problems such as cancer and Parkinson’s
disease. This review cannot make any recommendations of
the effectiveness and the dosage of qigong for patients with
depression. Particularly, it should be cautious to recommend
qigong to young adults who fulfill diagnostic criteria for
major depression or other mental disorders. Further rigor-
ously designed RCTs adhering to accepted standards of trial
methodology are required to determine more accurately the
efficacy and effectiveness of qigong and its long-term effect
on depressive symptoms. Particular attention should be paid
to how to optimize recruitment and how to motivate relevant
patients to take part in the studies.
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